Laxxon Medical is a disruptive biotech startup whose 3-D printing technology is transforming the pharmaceutical industry.
Laxxon Medical owns the exclusive rights to the development, production and commercialization of innovative drug delivery systems on the basis of a worldwide patented large-scale 3D screen printing.
Laxxon Medical owns the exclusive rights to the development, production and commercialization of innovative drug delivery systems on the basis of a worldwide patented large-scale 3D screen printing.
Location: United States, New York
Employees: 11-50
Founded date: 2017
Investors 1
| Date | Name | Website |
| - | bm-t betei... | bm-t.de |
Mentions in press and media 1
| Date | Title | Description |
| - | Settlement of the Swiss company Laxxon: 3D-printed medicines “Made in Jena” in the future | Laxxon optimises drug delivery thanks to a patented, innovative 3D screen printing process The technology company Laxxon Medical GmbH is settling in Jena and will in future develop and manufacture innovative medicines here on t... |